The Augmont Enterprises IPO GMP is currently at ₹380 as of August 24, 2026, according to the latest available grey market data. With the IPO price fixed at ₹788 per share, the current GMP indicates an estimated listing price of ₹1,168, representing a potential listing premium of 48.22% over the issue price.
The IPO has received strong investor interest, with the issue subscribed 7.83x overall as of the latest update at 10:35 AM on August 24.
| GMP Date | IPO Price | GMP | Subscription | Estimated Listing Price | Estimated Gain |
|---|---|---|---|---|---|
| 24-Aug-2026 | ₹788 | ₹380 | 5.29x | ₹1,168 | 48.22% |
| 23-Aug-2026 | ₹788 | ₹380 | 2.88x | ₹1,168 | 48.22% |
| 22-Aug-2026 | ₹788 | ₹395 | 2.88x | ₹1,183 | 50.13% |
| 21-Aug-2026 | ₹788 | ₹310 | 2.88x | ₹1,098 | 39.34% |
| 20-Aug-2026 | ₹788 | ₹300 | — | ₹1,088 | 38.07% |
| 19-Aug-2026 | ₹788 | ₹280 | — | ₹1,068 | 35.53% |
| 18-Aug-2026 | ₹788 | ₹190 | — | ₹978 | 24.11% |
The GMP has increased from ₹190 on August 18 to ₹380 on August 24. It reached a recent high of ₹395 on August 22 before moderating to ₹380.
At the latest GMP of ₹380, the estimated listing price is calculated as:
₹788 (IPO price) + ₹380 (GMP) = ₹1,168
This implies an estimated premium of 48.22% over the IPO price.
The Augmont Enterprises IPO has received strong demand across investor categories, with the overall issue subscribed 7.83x.
| Investor Category | Subscription |
| QIB | 1.91x |
| NII | 16.58x |
| S-NII (≤ ₹10 lakh) | 20.72x |
| B-NII (> ₹10 lakh) | 14.51x |
| RII | 7.52x |
| Employee | 4.44x |
| Overall | 7.83x |
The NII category recorded the highest overall subscription at 16.58x, while the retail investor portion was subscribed 7.52x. Within the NII segment, S-NII demand stood at 20.72x, compared with 14.51x for B-NII.
The QIB portion was subscribed 1.91x, while the employee category was subscribed 4.44x.
The latest GMP of ₹380 indicates strong unofficial market sentiment towards the IPO and points to a potential listing price of ₹1,168, based on the current grey market premium.
The strong subscription figures, particularly in the NII and retail categories, also indicate robust investor demand during the issue.
However, GMP is an unofficial indicator and can change before the actual listing. The estimated listing price should therefore not be treated as a guaranteed listing price. Investors should also consider the company’s fundamentals, valuation, financial performance and overall market conditions.
Related Tags

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.